Tech Company Financing Transactions

Caristo Diagnostics Funding Round

Forbion Capital Partners, GIMV and BioGeneration Ventures participated in a $79 million Series A funding round for Caristo Diagnostics. The funding round was announced on 4/17/2023.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

New Barclay House, 234 Botley Road
Oxford, England, OX2 0HP
UK

Phone

Undisclosed

Website

www.caristo.com

Email Address

[email protected]

Overview

Caristo was founded in 2018 by Cardiologists at the University of Oxford, following a decade of scientific research and technical development, to revolutionise diagnosis and treatment. With Care as one of our core values, we are committed to our mission of transforming health outcomes through clinical and scientific innovation. While we have known for over 50 years that heart attacks are caused by inflammation in coronary arteries (which supply blood to the heart), physicians have been unable to visualize and measure coronary inflammation with routine cardiac tests.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Frank Cheng

        

Co-Founder

Charalambos Antoniades

        

Co-Founder

Cheerag Shirodaria

        

Browse more venture capital transactions:

Prev: 4/17/2023: Wedio venture capital transaction
Next: 4/17/2023: Myxt venture capital transaction

Share this article

About Database of VC Transactions

We do our best to record all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary